![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 38, 34666-34673, September 20, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Department of Cell Biology, Cochin Institute, INSERM
U-567, CNRS UMR-8104 and University René-Descartes, Paris 75014, France, the § Department of Biochemistry, University of
Montreal, Montreal, Quebec H3C 3J7, Canada, and the
¶ Institut de Recherche Interdisciplinaire en Biologie Humaine et
Nucléaire, Université Libre de Bruxelles, B-1070
Bruxelles, Belgium
Although homo-oligomerization has been
reported for several G protein-coupled receptors, this phenomenon was
not studied at low concentrations of receptors. Furthermore, it is not
clear whether homo-oligomerization corresponds to an intrinsic property of nascent receptors or if it is a consequence of receptor activation. Here CCR5 receptor oligomerization was studied by bioluminescence resonance energy transfer (BRET) in cells expressing physiological levels of receptors. A strong energy transfer could be observed, in the
absence of ligands, in whole cells and in both endoplasmic reticulum and plasma membrane subfractions, supporting the hypothesis of a constitutive oligomerization that occurs early after biosynthesis. No change in BRET was observed upon agonist binding, indicating that
the extent of oligomerization is unrelated to the activation state of
the receptor. In contrast, a robust increase of BRET, induced by a
monoclonal antibody known to promote receptor clustering, suggests that
microaggregation of preformed receptor homo-oligomers can occur. Taken
together, our data indicate that constitutive receptor
homo-oligomerization has a biologically relevant significance and might
be involved in the process of receptor biosynthesis.
Constitutive Agonist-independent CCR5 Oligomerization and
Antibody-mediated Clustering Occurring at Physiological Levels of
Receptors*,
,
, and
*
This work was supported by grants from the Agence
Nationale pour la Recherche sur le SIDA the Association pour la
Recherche sur le Cancer, the Actions de Recherche Concertées of
the Communauté Française de Belgique, and the Canadian
Institute for Health Research.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
The on-line version of this article (available at
http://www.jbc.org) contains additional text and one figure.
Recipient of a fellowship from the Association pour la Recherche
sur la Polyarthrite Rhumatoïde.
Holder of a Canada Research Chair in Molecular and Cellular Pharmacology.
**
To whom correspondence should be addressed: Dépt.
de Biologie Cellulaire, Institut Cochin, Bât. G Roussy, 27, rue
du Fg. St. Jacques 75014 Paris, France. Tel.: 331-44-41-25-58; Fax:
331-44-41-25-57; E-mail: marullo@cochin.inserm.fr.
This article has been cited by other articles:
![]() |
R. L. Contento, B. Molon, C. Boularan, T. Pozzan, S. Manes, S. Marullo, and A. Viola CXCR4-CCR5: A couple modulating T cell functions PNAS, July 22, 2008; 105(29): 10101 - 10106. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-L. Guillaume, A. M. Daulat, P. Maurice, A. Levoye, M. Migaud, L. Brydon, B. Malpaux, C. Borg-Capra, and R. Jockers The PDZ Protein Mupp1 Promotes Gi Coupling and Signaling of the Mt1 Melatonin Receptor J. Biol. Chem., June 13, 2008; 283(24): 16762 - 16771. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kern, D. Hubbard, A. Amano, and G. D. Bryant-Greenwood Cloning, Expression, and Functional Characterization of Relaxin Receptor (Leucine-Rich Repeat-Containing G Protein-Coupled Receptor 7) Splice Variants from Human Fetal Membranes Endocrinology, March 1, 2008; 149(3): 1277 - 1294. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. B. Fredriksen and B. Bogen Chemokine-idiotype fusion DNA vaccines are potentiated by bivalency and xenogeneic sequences Blood, September 15, 2007; 110(6): 1797 - 1805. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. W. Nasser, S. K. Raghuwanshi, K. M. Malloy, P. Gangavarapu, J.-Y. Shim, K. Rajarathnam, and R. M. Richardson CXCR1 and CXCR2 Activation and Regulation: ROLE OF ASPARTATE 199 OF THE SECOND EXTRACELLULAR LOOP OF CXCR2 IN CXCL8-MEDIATED RAPID RECEPTOR INTERNALIZATION J. Biol. Chem., March 2, 2007; 282(9): 6906 - 6915. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. A. Berchiche, K. Y. Chow, B. Lagane, M. Leduc, Y. Percherancier, N. Fujii, H. Tamamura, F. Bachelerie, and N. Heveker Direct Assessment of CXCR4 Mutant Conformations Reveals Complex Link between Receptor Structure and G{alpha}i Activation J. Biol. Chem., February 23, 2007; 282(8): 5111 - 5115. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Gaibelet, T. Planchenault, S. Mazeres, F. Dumas, F. Arenzana-Seisdedos, A. Lopez, B. Lagane, and F. Bachelerie CD4 and CCR5 Constitutively Interact at the Plasma Membrane of Living Cells: A CONFOCAL FLUORESCENCE RESONANCE ENERGY TRANSFER-BASED APPROACH J. Biol. Chem., December 8, 2006; 281(49): 37921 - 37929. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Dupre, M. Robitaille, N. Ethier, L. R. Villeneuve, A. M. Mamarbachi, and T. E. Hebert Seven Transmembrane Receptor Core Signaling Complexes Are Assembled Prior to Plasma Membrane Trafficking J. Biol. Chem., November 10, 2006; 281(45): 34561 - 34573. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Wang, L. He, C. A. Combs, G. Roderiquez, and M. A. Norcross Dimerization of CXCR4 in living malignant cells: control of cell migration by a synthetic peptide that reduces homologous CXCR4 interactions. Mol. Cancer Ther., October 1, 2006; 5(10): 2474 - 2483. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Savi, J.-L. Zachayus, N. Delesque-Touchard, C. Labouret, C. Herve, M.-F. Uzabiaga, J.-M. Pereillo, J.-M. Culouscou, F. Bono, P. Ferrara, et al. The active metabolite of Clopidogrel disrupts P2Y12 receptor oligomers and partitions them out of lipid rafts PNAS, July 18, 2006; 103(29): 11069 - 11074. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. C. Kong, T. Fan, G. Varghese, B. F. O'Dowd, and S. R. George Agonist-Induced Cell Surface Trafficking of an Intracellularly Sequestered D1 Dopamine Receptor Homo-Oligomer Mol. Pharmacol., July 1, 2006; 70(1): 78 - 89. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-Y. Springael, P. N. Le Minh, E. Urizar, S. Costagliola, G. Vassart, and M. Parmentier Allosteric Modulation of Binding Properties between Units of Chemokine Receptor Homo- and Hetero-Oligomers Mol. Pharmacol., May 1, 2006; 69(5): 1652 - 1661. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Kota, P. J. Reeves, U. L. RajBhandary, and H. G. Khorana Opsin is present as dimers in COS1 cells: Identification of amino acids at the dimeric interface PNAS, February 28, 2006; 103(9): 3054 - 3059. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. H. Meyer, J.-M. Segura, K. L. Martinez, R. Hovius, N. George, K. Johnsson, and H. Vogel FRET imaging reveals that functional neurokinin-1 receptors are monomeric and reside in membrane microdomains of live cells PNAS, February 14, 2006; 103(7): 2138 - 2143. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Huttenrauch, B. Pollok-Kopp, and M. Oppermann G Protein-coupled Receptor Kinases Promote Phosphorylation and {beta}-Arrestin-mediated Internalization of CCR5 Homo- and Hetero-oligomers J. Biol. Chem., November 11, 2005; 280(45): 37503 - 37515. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Calebiro, T. de Filippis, S. Lucchi, C. Covino, S. Panigone, P. Beck-Peccoz, D. Dunlap, and L. Persani Intracellular entrapment of wild-type TSH receptor by oligomerization with mutants linked to dominant TSH resistance Hum. Mol. Genet., October 15, 2005; 14(20): 2991 - 3002. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Wilson, G. Wilkinson, and G. Milligan The CXCR1 and CXCR2 Receptors Form Constitutive Homo- and Heterodimers Selectively and with Equal Apparent Affinities J. Biol. Chem., August 5, 2005; 280(31): 28663 - 28674. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. F. Hamdan, M. Audet, P. Garneau, J. Pelletier, and M. Bouvier High-Throughput Screening of G Protein-Coupled Receptor Antagonists Using a Bioluminescence Resonance Energy Transfer 1-Based {beta}-Arrestin2 Recruitment Assay J Biomol Screen, August 1, 2005; 10(5): 463 - 475. [Abstract] [PDF] |
||||
![]() |
E. M. Pietila, J. T. Tuusa, P. M. Apaja, J. T. Aatsinki, A. E. Hakalahti, H. J. Rajaniemi, and U. E. Petaja-Repo Inefficient Maturation of the Rat Luteinizing Hormone Receptor: A PUTATIVE WAY TO REGULATE RECEPTOR NUMBERS AT THE CELL SURFACE J. Biol. Chem., July 15, 2005; 280(28): 26622 - 26629. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Wang, X. Sun, L. M. Bohn, and W. Sadee Opioid Receptor Homo- and Heterodimerization in Living Cells by Quantitative Bioluminescence Resonance Energy Transfer Mol. Pharmacol., June 1, 2005; 67(6): 2173 - 2184. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Percherancier, Y. A. Berchiche, I. Slight, R. Volkmer-Engert, H. Tamamura, N. Fujii, M. Bouvier, and N. Heveker Bioluminescence Resonance Energy Transfer Reveals Ligand-induced Conformational Changes in CXCR4 Homo- and Heterodimers J. Biol. Chem., March 18, 2005; 280(11): 9895 - 9903. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Balabanian, B. Lagane, J. L. Pablos, L. Laurent, T. Planchenault, O. Verola, C. Lebbe, D. Kerob, A. Dupuy, O. Hermine, et al. WHIM syndromes with different genetic anomalies are accounted for by impaired CXCR4 desensitization to CXCL12 Blood, March 15, 2005; 105(6): 2449 - 2457. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. El-Asmar, J.-Y. Springael, S. Ballet, E. U. Andrieu, G. Vassart, and M. Parmentier Evidence for Negative Binding Cooperativity within CCR5-CCR2b Heterodimers Mol. Pharmacol., February 1, 2005; 67(2): 460 - 469. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. S. Kang, C. Gustafsson, M. Morgelin, and L. M. F. Leeb-Lundberg B1 Bradykinin Receptor Homo-Oligomers in Receptor Cell Surface Expression and Signaling: Effects of Receptor Fragments Mol. Pharmacol., January 1, 2005; 67(1): 309 - 318. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Mesnier and J.-L. Baneres Cooperative Conformational Changes in a G-protein-coupled Receptor Dimer, the Leukotriene B4 Receptor BLT1 J. Biol. Chem., November 26, 2004; 279(48): 49664 - 49670. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Scaffidi, N. Petrovic, Y. P. Moodley, M. Fogel-Petrovic, K. M. Kroeger, R. M. Seeber, K. A. Eidne, P. J. Thompson, and D. A. Knight {alpha}v{beta}3 Integrin Interacts with the Transforming Growth Factor {beta} (TGF{beta}) Type II Receptor to Potentiate the Proliferative Effects of TGF{beta}1 in Living Human Lung Fibroblasts J. Biol. Chem., September 3, 2004; 279(36): 37726 - 37733. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Ayoub, A. Levoye, P. Delagrange, and R. Jockers Preferential Formation of MT1/MT2 Melatonin Receptor Heterodimers with Distinct Ligand Interaction Properties Compared with MT2 Homodimers Mol. Pharmacol., August 1, 2004; 66(2): 312 - 321. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. T. Toth, D. Ren, and R. J. Miller Regulation of CXCR4 Receptor Dimerization by the Chemokine SDF-1{alpha} and the HIV-1 Coat Protein gp120: A Fluorescence Resonance Energy Transfer (FRET) Study J. Pharmacol. Exp. Ther., July 1, 2004; 310(1): 8 - 17. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Milligan G Protein-Coupled Receptor Dimerization: Function and Ligand Pharmacology Mol. Pharmacol., July 1, 2004; 66(1): 1 - 7. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Rashid, B. F. O'Dowd, and S. R. George Minireview: Diversity and Complexity of Signaling through Peptidergic G Protein-Coupled Receptors Endocrinology, June 1, 2004; 145(6): 2645 - 2652. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. E. Breitwieser G Protein-Coupled Receptor Oligomerization: Implications for G Protein Activation and Cell Signaling Circ. Res., January 9, 2004; 94(1): 17 - 27. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Canals, D. Marcellino, F. Fanelli, F. Ciruela, P. de Benedetti, S. R. Goldberg, K. Neve, K. Fuxe, L. F. Agnati, A. S. Woods, et al. Adenosine A2A-Dopamine D2 Receptor-Receptor Heteromerization: QUALITATIVE AND QUANTITATIVE ASSESSMENT BY FLUORESCENCE AND BIOLUMINESCENCE ENERGY TRANSFER J. Biol. Chem., November 21, 2003; 278(47): 46741 - 46749. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hunzicker-Dunn, G. Barisas, J. Song, and D. A. Roess Membrane Organization of Luteinizing Hormone Receptors Differs between Actively Signaling and Desensitized Receptors J. Biol. Chem., October 31, 2003; 278(44): 42744 - 42749. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Trettel, S. Di Bartolomeo, C. Lauro, M. Catalano, M. T. Ciotti, and C. Limatola Ligand-independent CXCR2 Dimerization J. Biol. Chem., October 17, 2003; 278(42): 40980 - 40988. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Klco, T. B. Lassere, and T. J. Baranski C5a Receptor Oligomerization: I. DISULFIDE TRAPPING REVEALS OLIGOMERS AND POTENTIAL CONTACT SURFACES IN A G PROTEIN-COUPLED RECEPTOR J. Biol. Chem., September 12, 2003; 278(37): 35345 - 35353. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. H. Floyd, A. Geva, S. P. Bruinsma, M. C. Overton, K. J. Blumer, and T. J. Baranski C5a Receptor Oligomerization: II. FLUORESCENCE RESONANCE ENERGY TRANSFER STUDIES OF A HUMAN G PROTEIN-COUPLED RECEPTOR EXPRESSED IN YEAST J. Biol. Chem., September 12, 2003; 278(37): 35354 - 35361. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Terrillon, T. Durroux, B. Mouillac, A. Breit, M. A. Ayoub, M. Taulan, R. Jockers, C. Barberis, and M. Bouvier Oxytocin and Vasopressin V1a and V2 Receptors Form Constitutive Homo- and Heterodimers during Biosynthesis Mol. Endocrinol., April 1, 2003; 17(4): 677 - 691. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. J. Babcock, M. Farzan, and J. Sodroski Ligand-independent Dimerization of CXCR4, a Principal HIV-1 Coreceptor J. Biol. Chem., January 24, 2003; 278(5): 3378 - 3385. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |